(19)
(11) EP 1 183 539 A1

(12)

(43) Date of publication:
06.03.2002 Bulletin 2002/10

(21) Application number: 00937431.5

(22) Date of filing: 19.05.2000
(51) International Patent Classification (IPC)7: G01N 33/567, C12Q 1/00
(86) International application number:
PCT/SE0001/010
(87) International publication number:
WO 0070/347 (23.11.2000 Gazette 2000/47)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 19.05.1999 US 134844 P
14.06.1999 US 138675 P

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • AHMAD, Sultan
    St-Laurent,Quebec H4S 1Z9 (CA)
  • CAO, Jack
    St-Laurent,Quebec H4S 1Z9 (CA)
  • GRAZZINI, Eric
    St-Laurent,Quebec H4S 1Z9 (CA)
  • LEMBO, Paola
    St-Laurent,Quebec H4S 1Z9 (CA)
  • WALKER, Philippe
    St-Laurent,Quebec H4S 1Z9 (CA)

   


(54) ASSAYS FOR AGONISTS, AGONISTS AND INVERSE AGONISTS OF MELANIN CONCENTRATING HORMONE (MCH) BINDING TO THE SOMATOSTATIN-LIKE RECEPTOR (SLC-1)